Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:442-451.

Slides:

Advertisements

Similar presentations

Fig. 4-1, p Fig. 4-2, p. 109 Fig. 4-3, p. 110.

Advertisements

Mayrene Hernandez, DO Advanced ProMed Inc. Billing and Management Solutions Board Certified in Family Medicine Clinical Assistant Professor for NSU.

When Using DOPPS Slides. DOPPS Slide Use Guidelines.

Slides courtesy of Matt Hall Nottingham University Hospitals February 2011 Slides courtesy of Matt Hall Nottingham University Hospitals February 2011 Slides.

P.464. Table 13-1, p.465 Fig. 13-1, p.466 Fig. 13-2, p.467.

Fig. 11-1, p p. 360 Fig. 11-2, p. 361 Fig. 11-3, p. 361.

Table 6-1, p Fig. 6-1, p. 162 p. 163 Fig. 6-2, p. 164.

A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.

Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:

METHVEN S, MACGREGOR MS, TRAYNOR JP, O'REILLY DS, DEIGHAN CJ NEPHROL DIAL TRANSPLANT, SEPT 2010 Assessing proteinuria in chronic kidney disease: protein–creatinine.

Renal damage occurs in 1 out of 4 hypertensives Adapted from Leoncini et al. J Hypertens. 2008;26:

Trial profile Mann JF et al. Lancet 2008;372:

Lab (5): Renal Function test (RFT) (Part 2) T.A Nouf Alshareef T.A Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.

Are prediction equations for glomerular filtration rate useful for the long-term monitoring of type 2 diabetic patients? Ne´ stor Fontsere´, Isabel Salinas,

The FRET Study Source: Inoue T, Ikeda H, Nakamura T, et al. Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin.

© 2016 S. Karger AG, Basel. All rights reserved Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency.

Lab (5): Renal Function test (RFT) (Part 2)

A.M. Thompson, T.G. Pickering Kidney International

Am J Nephrol 2013;38: DOI: / Fig. 1. Study selection process.

Quantitative Analysis of Abdominal Aortic Calcification in CKD Patients Without Dialysis Therapy by Use of the Agatston Score Kidney Blood Press Res 2013;38:

Melody Sherwood, Peter A McCullough The Lancet Global Health

Creatinine-Based Glomerular Filtration Rates and Microalbuminuria for Detecting Metabolic Abnormalities in US Adults: The National Health and Nutrition.

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Locatelli et al. Am J Nephrol 2017;45: (DOI: / )

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Renal Function Testing

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

Figure 4 Interplay between acute kidney injury (AKI),

Fan et al. Am J Nephrol 2017;45: (DOI: / )

Kuwabara et al. Am J Nephrol 2017;45: (DOI: / )

Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease Martin et al. Am J Nephrol 2017;45: (DOI:

Bhandari et al. Am J Nephrol 2017;45: (DOI: / )

Differential expression of select miRNAs was validated in a second cohort of patients. Differential expression of select miRNAs was validated in a second.

Bushinsky et al. Am J Nephrol 2016;44: (DOI: / )

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology.

Management of hypertension in patients with chronic kidney disease

Figure 1 The burden of chronic kidney disease (CKD)

Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study Burst et al. Am J Nephrol 2017;45:

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease Torres et al. Am J.

Hammoud et al. Am J Nephrol 2016;44: (DOI: / )

Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients Sprague et al.

Jason T. Lee, MD, Vinit N. Varu, MD, Kenneth Tran, BS, Ronald L

Health ABC: Mortality risk by quintile of cystatin C

Chronic Kidney Disease in Diabetes

Melody Sherwood, Peter A McCullough The Lancet Global Health

End point Fenoldopam, n (%) Dopamine, n (%) p

Psychosocial Factors and 30-Day Hospital Readmission among Individuals Receiving Maintenance Dialysis: A Prospective Study Flythe et al. Am J Nephrol 2017;45:

Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.

I. Introduction American Journal of Kidney Diseases

Predictors of disease progression in patients with CKD

Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects Akizawa et.

Nat. Rev. Nephrol. doi: /nrneph

Langsford et al. Am J Nephrol 2017;45: (DOI: / )

Payan Schober et al. Am J Nephrol 2017;45: (DOI: / )

Volume 76, Issue 10, Pages (November 2009)

Volume 85, Issue 3, Pages (March 2014)

Nowak et al. Am J Nephrol 2016;44: (DOI: / )

Kai Singbartl, John A. Kellum Kidney International

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

Targeting Immunity in End-Stage Renal Disease

Volume 80, Issue 10, Pages (November 2011)

Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis.

Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients Kim et al. Am J Nephrol 2016;44:71-80.

Baseline demographics and clinical characteristics of 3,956 rosuvastatin-treated patients Donald G. Vidt, et al. Am J Cardiol 2006;97:1602–1606.

Nat. Rev. Nephrol. doi: /nrneph

Two-year changes in albumin-to-creatinine ratio across microalbuminuria at baseline. Two-year changes in albumin-to-creatinine ratio across microalbuminuria.

Correlations among chronic kidney disease (CKD) classification, urinary adiponectin level, eGFR, and ACR. (A) Correlation between CKD classification and.

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

Avasare et al. Am J Nephrol 2017;45:99-106 (DOI: / )

Presentation transcript:

Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:442-451 (DOI: 10.1159/000471894) Table 1. Baseline characteristics based on glomerular disease subtype (48 pregnancies in 43 women)

Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:442-451 (DOI: 10.1159/000471894) Table 2. Major fetal and maternal outcomes based on glomerular disease subtype (48 pregnancies in 43 women)

Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:442-451 (DOI: 10.1159/000471894) Fig. 1. Temporal trends in serum creatinine classified on the basis of glomerular disease subtype (including patients with complete laboratory data at all 3 time-points, n = 22, and excluding 1 patient with FSGS who presented with advanced stage 5 CKD).

Pregnancy Outcomes in Patients with Glomerular Disease Attending a Single Academic Center in North Carolina O'Shaughnessy et al. Am J Nephrol 2017;45:442-451 (DOI: 10.1159/000471894) Fig. 2. Temporal trends in urinary protein based on glomerular disease subtype (including patients with complete laboratory data at all 3 time-points, n = 18). * Grams of protein per gram of creatinine in a spot urine sample or, if unavailable, grams of protein in a 24-h urine collection.